This firm fixed-price purchase order was awarded to Bioivt, LLC by the National Institute of Allergy and Infectious Diseases, a civilian agency within the Department of Health and Human Services. The $18,575 contract is for the delivery of AD HUMAN CSF and has a period of performance through November 8, 2024. Bioivt is a leading global provider of biological specimens and value-added services, and has previously supported medical research programs across various federal agencies through prime...
This is a firm fixed-price delivery order contract awarded by the Defense Health Agency to Bioivt, LLC, a leading global provider of biological specimens and services. The contract, valued at $29,960, is for the acquisition of monkey and human (female) cryoplateable hepatocytes. The contract has an ultimate completion date of August 26, 2024. Bioivt, LLC is a prime contractor that has previously provided biological materials such as cryopreserved and cryoplateable hepatocytes, plasma, serum,...
This is a $149,940 firm-fixed-price purchase order awarded by the Department of the Army Medical Command to Bioivt, LLC, a leading provider of biological specimens and services. The contract is for the delivery of male rhesus monkey cryoplateable hepatocytes, with a completion date of September 30, 2020. Bioivt has previously provided similar biological materials such as cryopreserved and cryoplateable hepatocytes, plasma, serum, and urine to support medical research programs across federal...
Bioivt, LLC has been awarded a firm fixed price delivery order valued at one hundred twenty-six thousand dollars by the Department of the Army Medical Command. This delivery order was issued under multiple award contract W81XWH21D0004 to provide monkey cryoplateable hepatocytes in support of research being conducted by the Walter Reed Army Institute of Research. The delivery order has a period of performance through April 29, 2022 and does not contain any set aside designations. Bioivt will...
This federal contract award, valued at $34,376.60, was issued by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Bioivt, LLC, a for-profit limited liability company based in Westbury, New York. The contract is for the procurement of 27 vials of cryopreserved hepatocytes, which are specialized biological specimens used in scientific research and medical advancement. The contract award is not designated as a set-aside and was competitively awarded. Bioivt,...
This is a $15,540.00 firm fixed price delivery order contract awarded by the Defense Health Agency to Bioivt, LLC, a for-profit limited liability company. The contract is to provide male cynomolgus monkey hepatocytes and male rhesus monkey hepatocytes to support in vitro assays. The contract has a period of performance through September 30, 2024 and was awarded on June 18, 2024. There is no set-aside designation for this contract. Bioivt, LLC has past experience providing biological materials...
Bioivt, LLC was awarded a firm fixed price purchase order valued at $14,997 by the National Center for Advancing Translational Sciences within the Department of Health and Human Services. The contract has no set-aside designation. Under the award, Bioivt will assess the inhibition activity of a test article for common human nucleoside transporters, fulfilling the original agency solicitation. The place of performance is in Westbury, New York and all work must be completed by December 19, 2022....
This is a firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the U.S. Department of Defense, to Bioivt, LLC, a provider of biological specimens and services. The contract is for the delivery of 5 million units of male human cryoplateable hepatocytes, with a ceiling value of $75,000.00 and a period of performance ending on July 30, 2021. Bioivt has previously provided biological materials and services as a prime contractor and subcontractor to...
This is a $5,724,344 federal contract award issued by the National Institute of Neurological Disorders and Stroke (NINDS), a part of the National Institutes of Health (NIH), to Advanced Bioscience Laboratories, Inc. (ABL). The contract is a delivery order under the larger "Manufacturing and Nonclinical Studies Support for the Development of Therapeutic Biotechnology Products for Neurological-related Disorders" Indefinite Delivery Vehicle (IDV), which has a total ceiling value of $149.2...
This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), on behalf of the National Institute of Neurological Disorders and Stroke (NINDS), to Curia Global Inc. (doing business as Amri) for the non-GMP synthesis of up to 100 compounds in 2-10 milligram quantities. The purpose is to identify molecules that bind the KIAA0203 protein, which could potentially lead to the development of a new Alzheimer's drug. The contract has a period of performance from...